Core Specialty Insurance Holdings has filed a registration statement for an initial public offering (IPO) of its common stock, with existing shareholders selling the shares rather than the company issuing new equity.
The Form S-1, filed with the US Securities and Exchange Commission on November 16, 2026, states that Core Specialty will not sell any shares in the offering and will not receive any proceeds from the sale. Instead, all net proceeds will go to the selling shareholders.
The firm said the main aims of the IPO are to establish a public market for its common stock, facilitate future access to public equity markets and increase its visibility in the marketplace.
Core Specialty will, however, bear the costs associated with the sale, excluding underwriting discounts and commissions, which will be paid by the selling shareholders.
The filing names Corinthian DF Holdings, Cavello Bay Reinsurance, Aquiline Financial Services Fund IV, David P. Delaney Jr and Timothy D. Delaney among the greater-than-5% and selling shareholders.
J.P. Morgan and Goldman Sachs are acting as lead active book-running managers, with BMO Capital Markets as joint active book-running manager.
Core Specialty intends to list its common stock on the New York Stock Exchange under the ticker symbol CORE. As mentioned, the prospectus is preliminary and does not yet specify the number of shares to be offered or the expected IPO price.





